Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 2, 2013, Pages 272-277

  Chavarria, Laia ^a,b,c   Alonso, Juli ^b,d   García Martínez, Rita ^a   Simón Talero, MacArena ^a,c   Ventura Cots, Meritxell ^a,c   Ramírez, Clara ^a   Torrens, Maria ^a   Vargas, Víctor ^a,b,c   Rovira, Alex ^d   Córdoba, Juan ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Hospital d'Vall Hebron   (Spain)

Author keywords

acute hepatic encephalopathy; bloodbrain barrier; glutamine; leukoaraiosis; spectroscopy

Indexed keywords

CHOLINE; GLUTAMINE; INOSITOL; PROTEIN S100B;

ADULT; AGED; ARTICLE; BRAIN WATER; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MALE; METABOLIC ENCEPHALOPATHY; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; WHITE MATTER LESION;

AGED; BRAIN; BRAIN CHEMISTRY; BRAIN EDEMA; CHOLINE; FEMALE; FOLLOW-UP STUDIES; GLUTAMIC ACID; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROSPECTIVE STUDIES; S100 PROTEINS; WATER;

EID: 84873408651     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.173     Document Type: Article

References (40)

1. Cordoba J, Minguez B. Hepatic encephalopathy. Semin Liver Dis 2008; 28: 70-80.
2. Norenberg MD. Astroglial dysfunction in hepatic encephalopathy. Metab Brain Dis 1998; 13: 319-335.
3. Zemtsova I, Gorg B, Keitel V, Bidmon HJ, Schror K, Haussinger D. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology 2011; 54: 204-215.
4. Nguyen JH, Yamamoto S, Steers J, Sevlever D, Lin W, Shimojima N et al. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J Hepatol 2006; 44: 1105-1114.
5. Palomero-Gallagher N, Bidmon HJ, Cremer M, Schleicher A, Kircheis G, Rei-fenberger G et al. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cell Physiol Biochem 2009; 24: 291-306.
6. Mardini H, Smith FE, Record CO, Blamire AM. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyper-ammonaemia. J Hepatol 2011; 54: 1154-1160.
7. Shah NJ, Neeb H, Kircheis G, Engels P, Haussinger D, Zilles K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008; 41: 706-717.
8. Miese FR, Wittsack HJ, Kircheis G, Holstein A, Mathys C, Modder U et al. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic ence-phalopathy. World J Gastroenterol 2009; 15: 5157-5164.
9. Lodi R, Tonon C, Stracciari A, Weiger M, Camaggi V, Iotti S et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62: 762-766.
10. Chavarria L, Oria M, Romero-Gimenez J, Alonso J, Lope-Piedrafita S, Cordoba J. Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology 2010; 138: 1566-1573.
11. Poveda MJ, Bernabeu A, Concepcion L, Roa E, de ME, Zapater P et al. Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study. Neuroimage 2010; 52: 481-487.
12. Sawara K, Kato A, Yoshioka Y, Suzuki K. Brain glutamine and glutamate levels in patients with liver cirrhosis: assessed by 3.0-T MRS. Hepatol Res 2004; 30: 18-23.
13. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006; 44: 788-794.
14. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003; 97: 2806-2813.
15. Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res 2002; 940: 102-104.
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
17. Smith SA, Levante TO, Meier BH, Ernst RR. Computer simulations in magnetic resonance. an object-oriented programming approach. J Magn Reson Series A 1994; 106: 75-105.
18. Lemberg A, Fernandez MA. Hepatic encephalopathy, ammonia, glutamate, glu-tamine and oxidative stress. Ann Hepatol 2009; 8: 95-102.
19. Cordoba J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996; 24: 919-923.
20. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 1610-1616.
21. Haussinger D, Kircheis G, Fischer R, Schliess F, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000; 32: 1035-1038.
22. Cauli O, Lopez-Larrubia P, Rodrigo R, Agusti A, Boix J, Nieto-Charques L et al. Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. Gastroenterology 2011; 140: 638-645.
23. Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M et al. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2008; 23(7 Part 2): e111-e119.
24. Nath K, Saraswat VA, Krishna YR, Thomas MA, Rathore RK, Pandey CM et al. Quantification of cerebral edema on diffusion tensor imaging in acute-on-chronic liver failure. NMR Biomed 2008; 21: 713-722.
25. Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 2008; 28: 334-341.
26. Brugieres P, Thomas P, Maraval A, Hosseini H, Combes C, Chafiq A et al. Water diffusion compartmentation at high b values in ischemic human brain. AJNR Am J Neuroradiol 2004; 25: 692-698.
27. Schwarcz A, Ursprung Z, Berente Z, Bogner P, Kotek G, Meric P et al. In vivo brain edema classification: New insight offered by large b-value diffusion-weighted MR imaging. J Magn Reson Imaging 2007; 25: 26-31.
28. Kale RA, Gupta RK, Saraswat VA, Hasan KM, Trivedi R, Mishra AM et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
29. Chavarria L, Alonso J, Garcia-Martinez R, Aymerich FX, Huerga E, Jacas C et al. Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation. AJNR Am J Neuroradiol 2011; 32: 1510-1517.
30. Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP et al. Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology 2003; 124: 346-351.
31. Jayakumar AR, Valdes V, Norenberg MD. The Na-K-Cl cotransporter in the brain edema of acute liver failure. J Hepatol 2011; 54: 272-278.
32. Guevara M, Baccaro ME, Torre A, Gomez-Anson B, Rios J, Torres F et al. Hypo-natremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009; 104: 1382-1389.
33. McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med 1995; 333: 1260-1266.
34. Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604.
35. Tarasow E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J et al. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Hepatogastroenterology 2003; 50: 2149-2153.
36. Verma A, Saraswat VA, Radha KY, Nath K, Thomas MA, Gupta RK. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 2008; 28: 1095-1103.
37. Minguez B, Rovira A, Alonso J, Cordoba J. Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR Am J Neuroradiol 2007; 28: 1499-1500.
38. Fernandez-Cadenas I, Mendioroz M, Domingues-Montanari S, Del Rio-Espinola A, Delgado P, Ruiz A et al. Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients. Eur J Neurol 2011; 18: 826-835.
39. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010; 81: 192-197.
40. Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-2340.